Invent Medic publishes newsletter discussing how the company is approaching the application for FDA registration in the U.S., expanding its product pipeline and strengthening the market and sales team

Published the 11 December 2020Invent Medic today publishes a new edition of the company’s newsletter aimed at shareholders, investors, and other stakeholders. In this edition, CEO Karin Bryder comments that the company has been preparing for the submission for market registration of Efemia...
Download: Release
Read more